Aligos Therapeutics, Inc. Share-based Payment Arrangement, Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $1.36M, a 17.48% increase year-over-year.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.31M, a 37.02% increase year-over-year.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $1.46M, a 14.49% decline year-over-year.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $1.47M, a 28.19% decline year-over-year.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2025 was $5.04M, a 40.32% decline from fiscal 2024.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2024 was $8.45M, a 33.20% decline from fiscal 2023.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $12.65M, a 13.89% decline from fiscal 2022.
- Aligos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $14.69M, a 9.18% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.36M 10-Q · filed 2026-08-06 | $2.68M 10-Q · filed 2026-08-06 | $4.14M derived: sum of 3 quarters · filed 2026-08-06 | $5.60M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-07 | $2.77M derived: sum of 2 quarters · filed 2026-05-07 | $4.24M derived: sum of 3 quarters · filed 2026-05-07 | $5.40M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.92M derived: sum of 2 quarters · filed 2026-03-05 | $4.09M derived: sum of 3 quarters · filed 2026-08-06 | $5.04M 10-K · filed 2026-03-05 | ||
| 2025-09-30 | $1.47M 10-Q · filed 2025-11-06 | $2.63M derived: sum of 2 quarters · filed 2026-08-06 | $3.59M 10-Q · filed 2025-11-06 | $5.29M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $1.16M 10-Q · filed 2026-08-06 | $2.12M 10-Q · filed 2026-08-06 | $3.83M derived: sum of 3 quarters · filed 2026-08-06 | $5.87M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $959.00K 10-Q · filed 2026-05-07 | $2.66M derived: sum of 2 quarters · filed 2026-05-07 | $4.71M derived: sum of 3 quarters · filed 2026-05-07 | $6.76M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.75M derived: sum of 2 quarters · filed 2026-03-05 | $5.80M derived: sum of 3 quarters · filed 2026-03-05 | $8.45M 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $2.04M 10-Q · filed 2025-11-06 | $4.10M derived: sum of 2 quarters · filed 2025-11-06 | $6.75M 10-Q · filed 2025-11-06 | $9.33M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $2.06M 10-Q · filed 2025-08-06 | $4.70M 10-Q · filed 2025-08-06 | $7.29M derived: sum of 3 quarters · filed 2025-08-06 | $10.50M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $2.65M 10-Q · filed 2025-05-06 | $5.23M derived: sum of 2 quarters · filed 2025-05-06 | $8.44M derived: sum of 3 quarters · filed 2025-05-06 | $11.64M derived: sum of 4 quarters · filed 2025-05-06 | ||
| 2023-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $5.79M derived: sum of 2 quarters · filed 2025-03-10 | $8.99M derived: sum of 3 quarters · filed 2025-03-10 | $12.65M 10-K · filed 2025-03-10 | ||
| 2023-09-30 | $3.21M 10-Q · filed 2024-11-06 | $6.41M derived: sum of 2 quarters · filed 2024-11-06 | $10.07M 10-Q · filed 2024-11-06 | $13.49M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $3.20M 10-Q · filed 2024-08-06 | $6.86M 10-Q · filed 2024-08-06 | $10.28M derived: sum of 3 quarters · filed 2024-08-06 | $13.77M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $3.66M 10-Q · filed 2024-05-07 | $7.08M derived: sum of 2 quarters · filed 2024-05-07 | $10.57M derived: sum of 3 quarters · filed 2024-05-07 | $14.56M derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $6.91M derived: sum of 2 quarters · filed 2023-11-02 | $10.90M derived: sum of 3 quarters · filed 2023-11-02 | $14.69M 10-K · filed 2023-03-09 | ||
| 2022-09-30 | $3.49M 10-Q · filed 2023-11-02 | $7.49M derived: sum of 2 quarters · filed 2023-11-02 | $11.28M 10-Q · filed 2023-11-02 | $14.92M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $3.99M 10-Q · filed 2023-08-03 | $7.78M 10-Q · filed 2023-08-03 | $11.43M derived: sum of 3 quarters · filed 2023-08-03 | $15.02M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $3.79M 10-Q · filed 2023-05-04 | $7.44M derived: sum of 2 quarters · filed 2023-05-04 | $11.03M derived: sum of 3 quarters · filed 2023-05-04 | $14.48M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $7.24M derived: sum of 2 quarters · filed 2023-03-09 | $10.69M derived: sum of 3 quarters · filed 2023-03-09 | $13.46M 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $3.59M 10-Q · filed 2022-11-02 | $7.04M derived: sum of 2 quarters · filed 2022-11-02 | $9.81M 10-Q · filed 2022-11-02 | $11.10M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $3.45M 10-Q · filed 2022-08-04 | $3.45M 10-Q · filed 2021-08-05 | $6.20M 10-Q · filed 2022-08-04 | $6.21M 10-Q · filed 2021-08-05 | $7.50M derived: sum of 3 quarters · filed 2022-08-04 | $8.52M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $2.76M 10-Q · filed 2022-05-04 | $4.06M derived: sum of 2 quarters · filed 2022-05-04 | $5.07M derived: sum of 3 quarters · filed 2022-05-04 | $5.40M derived: sum of 4 quarters · filed 2022-05-04 | ||
| 2020-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.32M derived: sum of 2 quarters · filed 2022-03-10 | $2.64M derived: sum of 3 quarters · filed 2022-03-10 | $2.98M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $1.02M 10-Q · filed 2021-11-04 | $1.34M derived: sum of 2 quarters · filed 2021-11-04 | $1.67M 10-Q · filed 2021-11-04 | $1.82M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $327.00K 10-Q · filed 2021-08-05 | $658.00K 10-Q · filed 2021-08-05 | $806.00K derived: sum of 3 quarters · filed 2021-08-05 | $957.00K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $331.00K 10-Q · filed 2021-05-10 | $479.00K derived: sum of 2 quarters · filed 2021-05-10 | $630.00K derived: sum of 3 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $299.00K derived: sum of 2 quarters · filed 2021-03-23 | $752.00K 10-K · filed 2021-03-23 | |||
| 2019-09-30 | $151.00K 10-Q · filed 2020-11-25 | $604.00K 10-Q · filed 2020-11-25 |